Register for our free email digests:
Division of UnitedHealth Group Co.
Latest From Express Scripts Holding Co.
Antibiotic incentives, vaccine strategies, drug pricing, patent updates and more hot topics from the Biotechnology Innovation Organization's recent annual conference.
In the spirit of the BIO International Convention's partnering focus, Scrip covered a dealmaker survey and spoke to Bayer about some of its business development priorities on day two of the annual convention. We also report on a payer perspective, post-Brexit EMA rumors and investments in vaccines.
Celgene, Express Scripts, and Aetna discuss need for shared accountability, data sharing and value assessment at DIA meeting.
With US generic drug price erosion running at double digits, 2017 is expected to be a challenging year for the generic drug sector. Manufacturers are looking increasingly to complex generics, injectables and biosimilars as an offset, but it's unclear if wins in those areas will be enough to bridge the growth divide.
- Therapeutic Areas
- Prescription Solutions
- North America
- Parent & Subsidiaries
- UnitedHealth Group Co.
- Senior Management
Timothy Wicks, CEO
Jeffrey Grosklags, CFO
- Contact Info
Phone: (800) 788-4863
2300 Main St.
Irvine, CA 92614
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.